Immunotherapy with interleukin-2 after autologous bone marrow transplantation (ABMT) for acute myelogenous leukemia (AML).

被引：0
|
作者：
Massumoto, CM [1 ]
Macedo, MCA [1 ]
Saboya, R [1 ]
Silva, R [1 ]
Loterio, H [1 ]
Dzik, C [1 ]
Pallotta, R [1 ]
Chamone, DAF [1 ]
Dulley, F [1 ]
机构：
[1] UNIV SAO PAULO,FUNDACAO PRO SANGUE HEMOCENTRO,DEPT HAEMATOL,BR-05508 SAO PAULO,BRAZIL
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4566 / 4566
页数：1
相关论文
共 50 条
  • [41] INTERLEUKIN-2 IMMUNOTHERAPY IN CHILDREN WITH NEUROBLASTOMA AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    FAVROT, MC
    MICHON, J
    FLORET, D
    COCHAT, C
    NEGRIER, S
    MATHIOT, C
    COZE, C
    ZUCKER, JM
    FRANKS, CR
    BOUFFET, E
    PHILIP, T
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1990, 7 (03) : 275 - 284
  • [42] Induction of Tissue Factor by Interleukin-2 in Acute Myelogenous Leukemia (AML) Cells
    Tanaka, Masao
    Kishi, Tatsuo
    GROWTH FACTORS, 1990, 4 (01) : 1 - 8
  • [43] Leukemia-free survival after autologous bone marrow transplantation followed by interleukin-2 in fifty patients with acute leukemia in first remission.
    Blaise, D
    Attal, M
    Pico, JL
    Reiffers, J
    Stoppa, AM
    Bellanger, C
    Molina, L
    Nedelec, G
    Vernant, JM
    Legros, M
    Gabus, R
    Huguet, F
    Brandely, M
    Hercend, T
    Olive, D
    Maraninchi, D
    BLOOD, 1995, 86 (10) : 364 - 364
  • [44] ACUTE MYELOGENOUS LEUKEMIA (AML) AFTER MARROW TRANSPLANTATION - RECURRENCE IN DONOR CELLS
    SANTOS, GW
    BORGAONKAR, DS
    BLOOD, 1977, 50 (05) : 315 - 315
  • [45] INTERLEUKIN-2 THERAPY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES
    FEFER, A
    BENYUNES, MC
    MASSUMOTO, C
    HIGUCHI, C
    YORK, A
    BUCKNER, CD
    THOMPSON, JA
    SEMINARS IN ONCOLOGY, 1993, 20 (06) : 41 - 45
  • [46] LOW-DOSE IL-2 DURING 6 MONTHS AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR ACUTE MYELOID-LEUKEMIA (AML)
    FALKENBURG, JHF
    HOOFTMANDENOTTER, A
    VANDERELSHOUT, M
    VANDERMAREL, A
    KLUINNELEMANS, JC
    SCHAAFSMA, MR
    FIBBE, WE
    BRANDELY, M
    WILLEMZE, R
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1119 - 1119
  • [47] AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)
    PLOUVIER, E
    NOIR, A
    HERVE, P
    REVUE FRANCAISE DE TRANSFUSION ET IMMUNO-HEMATOLOGIE, 1985, 28 (05): : 503 - 508
  • [48] AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)
    PLOUVIER, E
    HERVE, P
    NOIR, A
    FLESCH, M
    CAHN, JY
    RACADOT, E
    HENON, P
    LUTZ, P
    BOILLETOT, A
    BEHAR, C
    MUNZER, M
    RAFFI, A
    ARCHIVES FRANCAISES DE PEDIATRIE, 1985, 42 (06): : 429 - 435
  • [49] AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN ACUTE-LEUKEMIA IN SECOND COMPLETE REMISSION
    MOZZANA, R
    LAMBERTENGHIDELILIERS, G
    BENAZZI, E
    POZZOLI, E
    BRUNO, E
    NOBILI, L
    PAGETTI, D
    POLLI, EE
    INTERNATIONAL JOURNAL OF CELL CLONING, 1985, 3 (04): : 279 - 279
  • [50] INTERLEUKIN-2 THERAPY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOCYTIC-LEUKEMIA - STUDIES IN A RELEVANT RAT MODEL FOR AML
    KLOOSTERMAN, TC
    MARTENS, ACM
    OSTERWALDER, B
    HAGENBEEK, A
    BONE MARROW TRANSPLANTATION, 1994, 14 (06) : 965 - 973
12345